Robert J. Gould

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert J. Gould:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Director Common Stock 484,864 $5,349,504 $11.03 19 Nov 2025 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36,000 26 Jun 2025 Direct
Turnstone Biologics Corp. Director Stock Option (Right to Buy) 12,770 03 Jun 2024 Direct

Insider Reports Filed by Robert J. Gould

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 19 Nov 2025 1 -$165,495 4 Director 21 Nov 2025, 16:15
FULC Fulcrum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 16:15
FULC Fulcrum Therapeutics, Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:20
TSBX Turnstone Biologics Corp. 03 Jun 2024 1 $0 4 Director 02 Jul 2024, 16:45
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Director 20 Jul 2023, 21:50
FULC Fulcrum Therapeutics, Inc. 27 Jun 2023 1 $0 4 Interim President & CEO, Director 29 Jun 2023, 16:16
FULC Fulcrum Therapeutics, Inc. 13 Jan 2023 1 -$101,490 4 Interim President & CEO, Director 13 Jan 2023, 17:33
FULC Fulcrum Therapeutics, Inc. 27 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:00
FULC Fulcrum Therapeutics, Inc. 07 Jun 2022 3 -$17,844 4 Director 08 Jun 2022, 19:33
FULC Fulcrum Therapeutics, Inc. 02 Jun 2022 9 -$10,493 4 Director 06 Jun 2022, 19:00
FULC Fulcrum Therapeutics, Inc. 07 Apr 2022 3 -$91,081 4 Director 11 Apr 2022, 17:00
FULC Fulcrum Therapeutics, Inc. 01 Apr 2022 9 -$1,537,755 4 Director 05 Apr 2022, 19:00